- $76.35m
- $123.94m
- $164.46m
- 57
- 96
- 13
- 56
Annual balance sheet for Ultralife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 10.7 | 8.41 | 5.63 | 10.2 | 6.85 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 21.1 | 20.2 | 27.8 | 31.8 | 29.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 64.5 | 66.5 | 79 | 90.2 | 97.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 25 | 25.8 | 23.9 | 24.7 | 44.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 138 | 160 | 168 | 178 | 220 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 18.7 | 18.9 | 28.9 | 23.7 | 29.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 20.9 | 41.9 | 52.2 | 52.9 | 86.5 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 117 | 118 | 116 | 125 | 134 |
Total Liabilities & Shareholders' Equity | 138 | 160 | 168 | 178 | 220 |
Total Common Shares Outstanding |